Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade N/A
- Symbol (CHMA)
- Company Chiasma, Inc.
- Price $3.76
- Changes Percentage (-6%)
- Change -$0.24
- Day Low $3.76
- Day High $4.10
- Year High $5.74
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/09/2021
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.57
- Trailing P/E Ratio -2.3903369357915
- Forward P/E Ratio -2.3903369357915
- P/E Growth -2.3903369357915
- Net Income $-74,779,000
Income Statement
Quarterly
Annual
Latest News of CHMA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
China's benchmark stock index on track for biggest daily gain since 2008
(Reuters) - China's stock markets have been on a tear since Beijing rolled out flurry of stimulus measures last week and over the weekend to jolt the beaten-down market and revive a slowing econom...
By Reuters | 2 hours ago -
Lightspeed 'well positioned to attract multiple suitors,' says Benchmark
Lightspeed Commerce (LSPD) shares surged over 14% after reports of a potential sale with JPMorgan's assistance. Benchmark analyst believes the company could attract various buyers, with a Buy rating a...
By Yahoo! Finance | 2 days ago -
Micron report 'bodes well' for Western Digital, says Benchmark
Benchmark analysts see positive implications for Western Digital (WDC) from Micron's strong Q4 report. They anticipate growth in NAND ASPs and shipments, projecting record sales and improved profitabi...
By Yahoo! Finance | 2 days ago